ABB and HPE Bring Intelligence to Industrial Plants
ABB and Hewlett Packard Enterprise (HPE) today announced a strategic global partnership that combines ABB’s industry-leading digital offerings, ABB AbilityTM, with HPE’s innovative hybrid information technology (IT) solutions. The partnership will provide customers with solutions that generate actionable insights from vast amounts of industrial data to increase the efficiency and flexibility of their operations and create competitive advantage.
Customers will benefit from ABB’s deep domain expertise in operations technologies (OT) and HPE’s leadership in information technologies (IT). ABB and HPE will deliver joint industry solutions that merge OT and IT to turn industrial data into insights and automatic action, combining widely-adopted cloud platforms like Microsoft Azure with IT systems running in corporate data centers and at the edge of the network. Employing the right mix of IT platforms will accelerate data processing in industrial plants and at the same time enable effective control of industrial processes across locations.
“This strategic partnership marks the next level of the digital industrial transformation. Together, we will bring intelligence from cloud-based solutions to on-premises deployments in industrial plants and data centers for greater uptime, speed and yield,” said ABB CEO Ulrich Spiesshofer. “ABB and HPE will deliver solutions that span the entire range of computing required by enterprises today, from the edge to the cloud to the core.”
With an installed base of 70 million connected devices, 70,000 digital control systems and 6,000 enterprise software solutions, ABB is a trusted leader in the industrial space, and has a four-decade-long history of creating digital solutions for customers. HPE in turn is a global leader in helping customers optimize their IT environments with secure, software-defined technologies that seamlessly integrate across traditional IT, multiple public and private clouds and the intelligent edge to drive key business outcomes.
“This alliance between two global leaders is unprecedented in terms of breadth and depth, and it will be ground-breaking for the progress of the Industrial Internet of Things,” said Meg Whitman, CEO, HPE. “Together with ABB, we will shape a digital industrial future where everything computes, equipping machines with intelligence to collaborate, allowing plants to flexibly adapt to changing demands, and enabling global supply chains to instantaneously react to incidents. This partnership will create exciting business opportunities for our joint customers.”
To provide a true end-to-end experience for customers, the ABB-HPE partnership will include co-innovation, co-development, joint go to market and service.
Research firm IDC forecasts that worldwide spending on the Internet of Things (IoT) will grow to $1.4 trillion in 2021 from an expected $800 billion in 2017. The largest investments are being made in areas such as manufacturing, transportation and utilities.1 To tap into the opportunities of the IoT, companies are investing in new solutions that digitize their industrial equipment and integrate it with their broader IT environments. By joining forces, ABB and HPE are bringing together the capabilities needed to accelerate this transformation.
Computing where it is required
Running data acquisition, analytics and control processes near industrial equipment helps customers avoid the latency, security and reliability issues associated with data communication through remote IT systems. ABB and HPE will jointly develop, market and service digital industrial solutions that help customers:
- Create deep insights and automatic action from industrial data – by running ABB AbilityTM applications on enterprise-grade IT systems close to the industrial equipment to accelerate the processing of vast amounts of data; and
- Manage and control industrial processes across the supply chain – by leveraging hybrid IT to provide a seamless experience from edge to cloud to core, making critical data available across locations.
The partnership will enable ABB Ability™ solutions to run on hybrid platforms such as HPE ProLiant for Microsoft Azure Stack, enabling customers to deploy applications to their preferred location – on HPE infrastructure in industrial plants and data centers or in the Microsoft Azure public cloud – to meet the specific requirements regarding performance, security or cross-site collaboration.
ABB and HPE will also deliver joint solutions for data centers, including
- Data center automation – to enable data center power, cooling and building systems automatically adapt to changing IT demands or incidents. To that end, ABB and HPE will integrate ABB AbilityTM Data Center Automation, which controls, monitors and optimizes mission-critical data center facilities infrastructure, with HPE OneView, HPE’s IT infrastructure automation software.
- Secure edge data center – specifically designed to run in harsh industrial environments, bringing enterprise-grade IT capacity closer to the point of data collection and machine control. This solution is being developed in collaboration between ABB, HPE and Rittal, the world’s largest manufacturer of IT racks, and will be an off-the-shelf ready IT data center solution for industrial customers enabling real-time insight and action.
The partnership was announced today at the HPE Discover conference in Madrid, where both companies demonstrated their first jointly developed solutions and prototypes.
ABB (ABBN: SIX Swiss Ex) is a pioneering technology leader in electrification products, robotics and motion, industrial automation and power grids, serving customers in utilities, industry and transport & infrastructure globally. Continuing a history of innovation spanning more than 125-years, ABB today is writing the future of industrial digitalization and driving the Energy and Fourth Industrial Revolutions. ABB operates in more than 100 countries with about 136,000 employees. www.abb.com
Hewlett Packard Enterprise is an industry leading technology company that enables customers to go further, faster. With the industry’s most comprehensive portfolio, spanning the cloud to the data center to workplace applications, our technology and services help customers around the world make IT more efficient, more productive and more secure.1 IDC Worldwide Semiannual Internet of Things Spending Guide, see https://www.idc.com/getdoc.jsp?containerId=prUS42799917
Phone: +41 43 317 71 11
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Dole’s Joint Venture Recycling Company Celebrates 25 Years21.5.2018 14:00 | Tiedote
Dole Food Company announced today that Recyplast S.A., an innovative plastic recycling company based in Costa Rica and with joint ownership including a subsidiary of Dole Fresh Fruit, recently surpassed 25 years in its mission to dramatically reduce and reuse agricultural waste. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005160/en/ Raul Martinez (right), General Manager of Dole Standard Fruit de Costa Rica, receives a plaque from Jose Miguel Ramirez, General Manager of Recyplast, in recognition of the contribution of Dole's banana plantations in the correct handling, storage, and provision of field plastic waste. The plastic recycling facility pioneered the collection of field plastics after use in banana growing operations in Costa Rica. This reuse and recycling process includes reclamation of plastic bags that protect bananas from weather and insects, as well as the collection of plastic twine used to prop the ba
ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/rilpivirine), the First 2-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV21.5.2018 13:11 | Tiedote
ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the European Commission has granted marketing authorisation for Juluca (dolutegravir 50mg/rilpivirine 25mg) for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor.1 Juluca is a 2-drug regimen of dolutegravir (ViiV Healthcare), the most widely prescribed integrase inhibitor worldwide,2 and rilpivirine (Janssen Sciences Ireland UC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson).1 Deborah Waterhouse, CEO ViiV Healthcare said, “The European Commission Decision for Juluca is very positive news for people living with
Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-121.5.2018 13:06 | Tiedote
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission has granted marketing authorisation for JULUCA® (dolutegravir 50mg [ViiV Healthcare]/rilpivirine 25mg [Janssen Sciences Ireland UC]).1 ViiV Healthcare, as the marketing authorisation holder, will market dolutegravir/rilpivirine in all countries in the European Union and European Economic Area. Dolutegravir/rilpivirine is the first two-drug regimen, once-daily, single-pill for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase inhibitor (INI).1 “The European Commission Decision for dolutegravir/rilpivirine marks a significant milestone in our 25-year commitment to make HIV history,” said Brian Woo
Chugai Presents Results of Two Pivotal Phase lll Studies for its Bispecific Antibody HEMLIBRA® at WFH 201821.5.2018 12:44 | Tiedote
Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) today announced that full results from HAVEN 3 study (NCT02847637) and HAVEN 4 study (NCT03020160) evaluating Chugai’s hemophilia A treatment HEMLIBRA® [generic name: emicizumab (genetical recombination)] are being presented at the World Federation of Hemophilia 2018 World Congress held in Glasgow, Scotland from May 20 to 24. HAVEN 3 study is conducted in people with hemophilia A without inhibitors, and HAVEN 4 study is conducted in people with hemophilia A with or without inhibitors. Results from both studies will be presented as late-breaking abstracts. “The results from HAVEN 3 study demonstrate that HEMLIBRA, which was created with Chugai’s proprietary antibody engineering technologies, can reduce the bleeding risk in people with hemophilia A without inhibitors. The intra-patient comparison in this study also shows a statistically significant reduction in bleeding by HEMLIBRA prophylaxis compared to factor VIII therapy, the current stand
STATS Unveils STATS GPS, the Most Advanced Technology for Athlete Monitoring21.5.2018 10:00 | Tiedote
Today, STATS, the worldwide leader in sports data and intelligence, unveiled STATS GPS, an innovative system that uses a revolutionary 50-Hz sampling frequency to provide the most advanced real-time GPS technology available. STATS GPS allows teams to monitor player performance with customizable metrics like accelerations/decelerations, energy expenditure, count of zone entries, and time, distance and power thresholds. The innovative solution uses real 50-Hz sampling frequency and allows practitioners to monitor up to 100 players in real-time and post session with over 300 GPS, IMU and HR derived metrics. Embedded in the GPS vests are textile heart-rate sensors, making STATS GPS the most advanced technology on the market. “Teams and conditioning coaches need the latest technology to ensure players stay at peak health and fitness during long seasons,” said Ryan Paterson, Chief Global Officer at STATS. “With STATS GPS’ new 50-Hz technology, teams can instantly get performance information,
Sofinnova Partners Appoints Dr. Martin T. Rothman as Venture Partner21.5.2018 09:00 | Tiedote
Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, has appointed Dr. Martin T. Rothman as Venture Partner. Dr. Rothman brings forty years of experience and a strong international network in the medical field to Sofinnova Partners. As Venture Partner, Dr. Rothman will focus on helping the team identify and evaluate promising medical device companies and on mentoring entrepreneurs and physicians launching clinical innovations. Sofinnova Partners and Dr. Rothman have closely collaborated over many years. Dr. Rothman is the founder of LimFlow and an independent board member of HighLife, both portfolio companies of Sofinnova Partners. Until recently, he was Vice President of medical affairs for coronary, structural heart and renal denervation for Medtronic, based in Santa Rosa (CA), a position he held since 2010. He was involved in the development of the renal denervation program, the Trans-Aortic Valve Replacement program, and the Medtronic percutaneo
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme